Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 13.36 is 34% above its 5-year average of 9.94, near the high end of its 5-year range (3.61–15.99).
As of the fiscal period ended Tuesday, June 30, 2026. 14.87% above its 12-month average of 11.63.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.36.
QUICK RATIO (ACID-TEST)
13.36
QUICK RATIO (ACID-TEST) AVG TTM
11.63
QUICK RATIO (ACID-TEST) AVG 3Y
9.53
QUICK RATIO (ACID-TEST) AVG 5Y
9.94
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+14.87%
CURRENT VS 3Y AVG
+40.23%
CURRENT VS 5Y AVG
+34.37%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+298.29%
vs the sector median at left
PepGen Inc.
Market Cap
$159.78M
Quick Ratio (Acid-Test)
13.36
TTM Avg
11.63
3Y Avg
9.53
5Y Avg
9.94
Market Cap
$159.80M
Quick Ratio (Acid-Test)
20.14
TTM Avg
22.07
3Y Avg
21.46
5Y Avg
19.43
Market Cap
$159.22M
Quick Ratio (Acid-Test)
0.84
TTM Avg
0.97
3Y Avg
0.83
5Y Avg
1.00
Market Cap
$159.14M
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.19
3Y Avg
1.52
5Y Avg
2.42
Market Cap
$162.04M
Quick Ratio (Acid-Test)
2.45
TTM Avg
5.00
3Y Avg
7.69
5Y Avg
7.91
Market Cap
$165.27M
Quick Ratio (Acid-Test)
7.98
TTM Avg
13.57
3Y Avg
13.59
5Y Avg
18.24
Market Cap
$165.32M
Quick Ratio (Acid-Test)
5.58
TTM Avg
2.96
3Y Avg
5.18
5Y Avg
6.05
Market Cap
$153.79M
Quick Ratio (Acid-Test)
1.69
TTM Avg
1.79
3Y Avg
2.66
5Y Avg
3.67
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PepGen Inc. (PEPG) | $159.78M | 13.36 | 11.63 | 9.53 | 9.94 |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | 20.14 | 22.07 | 21.46 | 19.43 |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | 0.84 | 0.97 | 0.83 | 1.00 |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | 1.70 | 1.19 | 1.52 | 2.42 |
| Quanterix Corporation (QTRX)vs › | $162.04M | 2.45 | 5.00 | 7.69 | 7.91 |
| Inogen, Inc. (INGN)vs › | $156.22M | 2.34 | 2.40 | 2.87 | 3.55 |
| Nkarta, Inc. (NKTX)vs › | $165.27M | 7.98 | 13.57 | 13.59 | 18.24 |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 5.58 | 2.96 | 5.18 | 6.05 |
| Neuronetics, Inc. (STIM)vs › | $153.79M | 1.69 | 1.79 | 2.66 | 3.67 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | 0.45 | 0.24 | 0.20 | 0.38 |
Quick Ratio
13.36
Excludes inventory
Current Ratio
13.36
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 13.36 |
| 2026-03-31 | 14.98 |
| 2025-12-31 | 11.94 |
| 2025-09-30 | 13.15 |
| 2025-06-30 | 4.74 |
| 2025-03-31 | 4.95 |
| 2024-12-31 | 7.41 |
| 2024-09-30 | 8.47 |
| 2024-06-30 | 7.45 |
| 2024-03-31 | 15.78 |
| 2023-12-31 | 6.43 |
| 2023-09-30 | 6.35 |
| 2023-06-30 | 8.88 |
| 2023-03-31 | 9.35 |
| 2022-12-31 | 9.88 |
| 2022-09-30 | 13.46 |
| 2022-06-30 | 11.17 |
| 2022-03-31 | 7.93 |
| 2021-12-31 | 13.56 |
| 2021-09-30 | 15.99 |
| 2021-06-30 | 3.61 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
